Ownes & Minor (OMI) Misses Q4 EPS by 11c, Revenue Beats; Guides FY23
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Owens & Minor Reports Fourth Quarter and Full Year 2022 Financial Results
February 28, 2023 6:05 AM ESTPatient Direct Q4 revenue up 135%, or 10.3% on an adjusted basis for the Apria Acquisition 2022 full year operating cash flow of $325 million Operating Model Realignment Program expected to improve profitability & cash flow by approximately: $30 million of Adjusted Operating Income in 2023 $200 million of Adjusted Operating Income by 2025 $250-$400 million of working capital benefit by 2025
RICHMOND, Va.--(BUSINESS WIRE)-- Owens & Minor, Inc. (NYSE-OMI) today reported financial results for the fourth quarter and the year ended December 31, 2022, as summarized in the table... More
